Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ventas, Inc. Common Stock (NY: VTR )

66.89 +0.53 (+0.80%)
Official Closing Price Updated: 7:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ventas, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Earnings Scheduled For February 9, 2023
Companies Reporting Before The Bell • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion. 
Via Benzinga
What 4 Analyst Ratings Have To Say About Ventas
Via Benzinga
The Latest Analyst Ratings for Ventas
Via Benzinga
8 Analysts Have This to Say About Ventas
Via Benzinga
Expert Ratings for Ventas
Analysts have provided the following ratings for Ventas (NYSE:VTR) within the last quarter: 
Via Benzinga
The 7 Best Beaten-Down Warren Buffett Stocks to Buy
Investors will want to take a close look at these beaten-down Warren Buffett stocks to buy for long-term appreciation. 
Via InvestorPlace
Ventas Inc. REIT: Relief Rally Gains New Strength
While quite a few real estate investment trusts (REITs) are just now coming off of new lows, Ventas Inc. (NYSE: VTR) is up to a three-month high.  
Via Benzinga
3 Unloved REIT Sectors That Are On Fire
More than 200 publicly traded real estate investment trusts (REITs) across 13 sectors are traded on the stock market, according to the National Association of Real Estate Investment Trusts (Nareit)... 
Via Benzinga
5 Must-Buy REITs for Your January Buy List
Here are five exceptional REITs to buy that happen to offer consistent growth and healthy passive income for long-term investors right now. 
Via InvestorPlace
2 High-Yield Dividend Stocks to Buy Before the End of 2022
These two stocks are positioned for growth in 2023. 
Via The Motley Fool
7 Analysts Have This to Say About Ventas
Within the last quarter, Ventas (NYSE:VTR) has observed the following analyst ratings: 
Via Benzinga
Analyst Ratings for Ventas
Analysts have provided the following ratings for Ventas (NYSE:VTR) within the last quarter: 
Via Benzinga
These 2 High-Yield Healthcare REITs Are Holding Up Better Than The Overall Market In 2022
Real estate investment trusts (REITs) operating in the healthcare sector, tend to have a trailing 10-year return of 11.6%, according to SP Global. 
Via Benzinga
This High-Yield Dividend Stock May Finally Be Ready to Start Growing Again
Ventas was hit hard during the early days of the coronavirus pandemic, but it is on the cusp of a recovery. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
From A to Z: All The REITs Hitting New 52-Week Lows This Week
From A to Z: All The REITs Hitting New 52-Week Lows This Week Real estate investment trusts (REITs) — and there are a lot of them — have gone from a New York Stock Exchange favorite to a stock to steer... 
Via Benzinga
Jim Cramer Says Stay Away From This Cybersecurity Company; He's Been 'Against Them The Whole Way Down'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said BlackBerry Limited (NYSE: BB) is losing money and he's been "against them the whole way down." 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  During Monday's trading, 528 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
Upgrades 
Via Benzinga
This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors
SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma... 
Via Benzinga
Tilray Brands To Rally Over 45%? Here Are 5 Other Price Target Changes For Monday
Cantor Fitzgerald raised Tilray Brands, Inc. (NASDAQ: TLRY) price target from $4.15 to $4.5. Cantor Fitzgerald analyst Pablo Zuanic maintained a Neutral rating on the stock. Tilray Brands shares fell... 
Via Benzinga
7 Undervalued REITs to Buy With Serious Profit Potential
In investing circles, undervalued REITs are among the most sought-after asset classes, but these ones possess added advantages. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 456 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  Monday saw 825 companies set new 52-week lows. 
Via Benzinga
5 REITs Now Hitting New 2022 Lows
Some real estate investment trusts (REITs) are hitting new year-to-date lows as the effects of Fed Chair Jerome Powell’s hawkish remarks at this year’s Jackson Hole, Wyoming, retreat sink in. His... 
Via Benzinga
Raymond James Maintains Strong Buy Rating for Ventas: Here's What You Need To Know
Raymond James has decided to maintain its Strong Buy rating of Ventas (NYSE:VTR) and lower its price target from $60.00 to $55.00. Shares of Ventas are trading up 0.91% over the last 24 hours, at... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 1076 companies hit new 52-week lows. 
Via Benzinga
HP To $33, Plus Citigroup Predicts $204 For Baidu
Credit Suisse cut the price target for HP Inc. (NYSE: HPQ) from $39 to $33. HP shares fell 6.6% to $29.05 in pre-market trading. 
Via Benzinga
7 Safe Investments for Seniors to Consider in 2022
Keep your nest egg safe with these save investments for seniors to consider in 2022. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.